The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
Facilities
Facilities
Eurofins continues to make progress in leasing less, owning more strategic sites
Investments in its network include the company’s CDMO business in the Toronto area, where it is building a new GMP biologics facility slated for completion in 2026.
Feb. 3, 2026
Facilities
Lilly to invest $3.5B in injectable drug, device manufacturing facility in Pennsylvania
Jan. 30, 2026
Facilities
US biomanufacturing investment sees 20% spike since 2024: report
Jan. 30, 2026
Facilities
AstraZeneca to invest $15B in manufacturing, R&D in China through 2030
Jan. 29, 2026
Facilities
Roche’s Genentech more than doubles investment in NC manufacturing site to $2B
Jan. 20, 2026
Facilities
J&J secures tariff exemption in drug pricing deal with Trump administration
Jan. 9, 2026
Facilities
Daiichi Sankyo invests $1.9B to boost ADC production globally
Jan. 7, 2026
Facilities
Eli Lilly plans to invest $6B in new API manufacturing facility in Alabama
Dec. 10, 2025
Facilities
Ardena’s US expansion positions the CDMO for growth amid geopolitical uncertainty
Dec. 9, 2025
Looking for Something?
Load More Content
